Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Valeant Pharmaceuticals has purchased Probiotica Laboratorios, a provider of sports nutrition and food supplements in Brazil, for R$150m.
Subscribe to our email newsletter
The transaction is expected to be immediately accretive.
Probiotica currently markets a full line of OTC sports nutrition products and other food supplements, with a 30% share of the market.
Valeant chairman and CEO Michael Pearson said they believe that they have a unique opportunity not only in Brazil, but in potential export markets as well.
"Probiotica’s strong reputation in Brazil makes it a perfect fit into our growing consumer portfolio," Pearson added.